| | ATP8A2, ATXN8OS +2048 more | Copy number loss | See cases | |
| | | Copy number gain | See cases | |
| | LOC126861801, LOC126861802 +2047 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LOC126861839, LOC126861840 +2045 more | Copy number gain | See cases | |
| | LOC130009480, LOC130009481 +488 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LOC124849292, LOC124849293 +2028 more | Copy number gain | See cases | |
| | LOC130009376, LOC130009377 +620 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LOC130009743, LOC130009744 +2024 more | Copy number gain | See cases | |
| | LOC130009548, LOC130009549 +2024 more | Copy number gain | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number loss | See cases | |
| | LOC126861732, LOC126861733 +213 more | Copy number loss | See cases | |
| | RBM26-AS1, RCBTB1 +1004 more | Copy number gain | See cases | |
| | LOC130009757, LOC130009758 +780 more | Copy number loss | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number loss | See cases | |
| | LOC130009739, LOC130009740 +992 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | BRCA2, LOC106721785 +1 more | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | BRCA2, LOC106721785 +1 more | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +1 more | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | BRCA2, LOC106721785 +1 more | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +1 more | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +2 more | Deletion | Hereditary breast ovarian cancer syndrome +1 more | |
| | | Single nucleotide variant | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant | Hereditary breast ovarian cancer syndrome +3 more | |
| | | Duplication | not provided | |
| | | Deletion | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +1 more | Deletion | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +1 more | Deletion | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +3 more | Deletion | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +1 more | Deletion | Hereditary breast ovarian cancer syndrome | |
| | LOC106721785, LOC112163653 +3 more | Deletion | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant | Hereditary breast ovarian cancer syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant | Breast-ovarian cancer, familial, susceptibility to, 2 +1 more | |
| | | Single nucleotide variant | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | not specified | |
| | | Single nucleotide variant (5 prime UTR variant) | not specified +2 more | GConflicting classifications of pathogenicity |
| | | Duplication | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Familial cancer of breast | |
| | | Insertion (non-coding transcript variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | not specified | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Deletion (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Insertion (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +1 more | |
| | | Deletion (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | not specified +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Indel (5 prime UTR variant) | not specified | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (5 prime UTR variant) | not specified | |
| | | Single nucleotide variant (5 prime UTR variant) | not specified +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Deletion (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Deletion (splice donor variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | BRCA2-related condition +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +1 more | |
| | | Single nucleotide variant (splice donor variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (splice donor variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (splice donor variant) | Hereditary breast ovarian cancer syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (splice donor variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (splice donor variant) | Fanconi anemia complementation group D1 +2 more | GConflicting classifications of pathogenicity |
| | | Deletion (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Microsatellite (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Microsatellite (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | not provided +1 more | |